Filing Details

Accession Number:
0001209191-18-007239
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-02 19:55:54
Reporting Period:
2018-01-31
Accepted Time:
2018-02-02 19:55:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Healthcare Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216850 B Bill Rutherford One Park Plaza
Nashville TN 37203
Cfo And Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-01 9,832 $5.34 41,269 No 4 M Direct
Common Stock Acquisiton 2018-02-01 27,594 $5.98 68,863 No 4 M Direct
Common Stock Acquisiton 2018-02-01 16,554 $6.48 85,417 No 4 M Direct
Common Stock Acquisiton 2018-02-01 9,829 $7.47 95,426 No 4 M Direct
Common Stock Acquisiton 2018-02-01 5,518 $10.92 100,764 No 4 M Direct
Common Stock Acquisiton 2018-02-01 9,829 $11.36 110,593 No 4 M Direct
Common Stock Acquisiton 2018-02-01 5,518 $15.91 116,111 No 4 M Direct
Common Stock Disposition 2018-02-01 14,976 $102.24 101,135 No 4 F Direct
Common Stock Disposition 2018-02-01 24,700 $101.98 76,435 No 4 S Direct
Common Stock Disposition 2018-02-01 23,762 $102.87 52,673 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Right Acquisiton 2018-01-31 70,900 $0.00 70,900 $101.16
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 9,832 $0.00 9,832 $5.34
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 16,556 $0.00 16,556 $5.98
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 11,038 $0.00 11,038 $5.98
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 5,518 $0.00 5,518 $6.48
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 11,036 $0.00 11,036 $6.48
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 9,829 $0.00 9,829 $7.47
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 5,518 $0.00 5,518 $10.92
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 9,829 $0.00 9,829 $11.36
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-01 5,518 $0.00 5,518 $15.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,900 2019-01-31 2028-01-31 No 4 A Direct
0 2019-02-25 No 4 M Direct
0 2019-08-27 No 4 M Direct
0 2019-08-27 No 4 M Direct
0 2011-08-27 2019-08-27 No 4 M Direct
0 2019-08-27 No 4 M Direct
0 2012-02-25 2019-02-25 No 4 M Direct
0 2010-08-27 2019-08-27 No 4 M Direct
0 2019-02-25 No 4 M Direct
0 2019-08-27 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.58 to $102.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.57 to $103.19, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.
  4. Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  5. On February 25, 2009, the reporting person was granted an option to purchase 29,494 shares of common stock, which vest upon achievement of certain predetermined investment return targets. 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of the closing of the initial public offering of the Issuer's securities on March 15, 2011, 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2011 and 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2012.
  6. Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  7. The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested.
  8. The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.
  9. The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.
  10. The option vested at the end of fiscal year 2012 based upon the achievement of certain annual EBITDA performance targets.
  11. The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets.